01513 麗珠醫藥
按盤價 
26.100 -0.200 (-0.760%) | 2024/12 - 末期 人民幣(千¥) | 2023/12 人民幣(千¥) | 2022/12 人民幣(千¥) | 2021/12 人民幣(千¥) | 2020/12 人民幣(千¥) | |
| 經營活動之現金流量 | 2,978,848 | 3,248,934 | 2,772,671 | 1,902,328 | 2,160,761 |
| 投資活動之現金流量 | (660,328) | (708,374) | (1,229,870) | (1,876,900) | (467,844) |
| 融資活動之現金流量 | (2,485,883) | (1,656,881) | (720,356) | (815,018) | (518,042) |
| 現金及等同現金之增加/(減少) | (167,363) | 883,680 | 822,446 | (789,590) | 1,174,874 |
| 期初之現金及現金等價物 | 10,976,366 | 10,072,643 | 9,125,310 | 9,952,050 | 8,854,186 |
| 匯率變動之影響 | 8,814 | 20,044 | 124,887 | (37,150) | (77,010) |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之現金及現金等價物 | 10,817,817 | 10,976,366 | 10,072,643 | 9,125,310 | 9,952,050 |
| 股東應佔溢利/(虧損) (千) | RMB 2,061,096 |
| 增長率 | 5.500% |
| 每股盈利/(虧損) | RMB 2.240 |
| 每股帳面資產淨值 (¥) | RMB 15.211 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
